Fennec Pharmaceuticals (FENC) Other Non Operating Income (2010 - 2025)
Fennec Pharmaceuticals posted quarterly Other Non Operating Income of -$2.0 million for Q4 2025, down 7488.89% year-on-year from $27730.8 in Q4 2024, and down 68200.0% on a QoQ basis from -$3000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) has 16 years of Other Non Operating Income data on file, last reported at -$2.0 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non Operating Income fell 7488.89% year-over-year to -$2.0 million; the trailing twelve-month figure through Dec 2025 stood at -$2.0 million (down 2365.85% YoY), and the FY2025 full-year result was -$2.0 million, down 2365.85% from the prior year.
- Other Non Operating Income for Q4 2025 stood at -$2.0 million, down from -$3000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $17000.0 in Q2 2025 and bottomed at -$2.0 million in Q4 2025.
- The 5-year median for Other Non Operating Income is -$3000.0 (2022), against an average of -$111473.7.
- The widest annual swing landed in 2023, when Other Non Operating Income soared 400.0%; it then plunged 7488.89% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at -$1000.0 in 2021, then sank by 200.0% to -$3000.0 in 2022, then soared by 166.67% to $2000.0 in 2023, then tumbled by 1450.0% to -$27000.0 in 2024, then slumped by 7488.89% to -$2.0 million in 2025.
- The last three Other Non Operating Income figures came in at -$2.0 million (Q4 2025), -$3000.0 (Q3 2025), and $17000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.05 Mn |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | -27,000.00 |
| Jun 30, 2024 | -17,000.00 |
| Mar 31, 2024 | -38,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | -11,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | -4,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Mar 31, 2021 | -4,000.00 |
| Dec 31, 2020 | -5,000.00 |
| Sep 30, 2020 | -8,000.00 |
| Jun 30, 2020 | 13,000.00 |
| Mar 31, 2020 | -9,000.00 |
| Dec 31, 2019 | -8,000.00 |
| Sep 30, 2019 | 1,000.00 |
| Jun 30, 2019 | -10,000.00 |
| Dec 31, 2018 | 6,000.00 |
| Mar 31, 2018 | -3,000.00 |
| Dec 31, 2017 | 332,000.00 |
| Sep 30, 2017 | -183,000.00 |
| Jun 30, 2017 | -4,000.00 |
| Mar 31, 2017 | -1,000.00 |
| Dec 31, 2016 | -2,000.00 |
| Jun 30, 2016 | -3,000.00 |
| Mar 31, 2016 | 43,000.00 |
| Dec 31, 2015 | 11,000.00 |
| Sep 30, 2015 | 216,000.00 |
| Jun 30, 2015 | 385,000.00 |
| Mar 31, 2015 | 625,000.00 |
| Dec 31, 2014 | 358,000.00 |
| Sep 30, 2014 | 619,000.00 |
| Jun 30, 2014 | 181,000.00 |
| Mar 31, 2014 | -2.66 Mn |
| Dec 31, 2013 | 3.79 Mn |
| Sep 30, 2013 | -7,000.00 |
| Jun 30, 2013 | 2,000.00 |
| Dec 31, 2012 | -5,000.00 |
| Mar 31, 2012 | -4,000.00 |
| Dec 31, 2011 | 9,000.00 |
| Sep 30, 2010 | 28,000.00 |